Qiubing Chen

2.5k total citations · 3 hit papers
40 papers, 2.0k citations indexed

About

Qiubing Chen is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Qiubing Chen has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Biomedical Engineering and 7 papers in Biomaterials. Recurrent topics in Qiubing Chen's work include RNA Interference and Gene Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Qiubing Chen is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Qiubing Chen collaborates with scholars based in China, United States and Switzerland. Qiubing Chen's co-authors include Bo Xiao, Hao Yin, Yuejun Kang, Liang Zeng, Menghang Zu, Liyong Luo, Didier Merlin, Xinlin Lei, Zhigang Xu and Ying Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Nature Biotechnology.

In The Last Decade

Qiubing Chen

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a

2022 272 citations Shuhan Lu, Kun Zhang et al. Nature Biomedical Engineering profile →
Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation

2021 233 citations Qiubing Chen, Qian Li et al. Acta Pharmaceutica Sinica B profile →
Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation

2023 124 citations Qiubing Chen, Menghang Zu et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qiubing Chen China	24	1.1k	437	292	241	227	40	2.0k
Ali Dehshahri Iran	31	1.9k 1.7×	541 1.2×	505 1.7×	264 1.1×	426 1.9×	91	2.9k
Munira Momin India	24	924 0.8×	585 1.3×	557 1.9×	216 0.9×	177 0.8×	85	2.7k
Jenny K.W. Lam Hong Kong	34	2.0k 1.8×	370 0.8×	467 1.6×	155 0.6×	242 1.1×	89	3.7k
Bruno Payré France	23	512 0.5×	194 0.4×	174 0.6×	192 0.8×	229 1.0×	54	1.7k
Yuhong Zhen China	26	720 0.6×	360 0.8×	313 1.1×	198 0.8×	81 0.4×	69	2.0k
Sisi Lin China	19	709 0.6×	665 1.5×	173 0.6×	114 0.5×	155 0.7×	40	1.8k
Zhan Zhang United States	13	1.2k 1.0×	240 0.5×	371 1.3×	99 0.4×	396 1.7×	19	2.3k
Young Bong Kim South Korea	25	755 0.7×	340 0.8×	261 0.9×	134 0.6×	180 0.8×	111	1.9k
Amanda E. Brooks United States	19	837 0.7×	303 0.7×	586 2.0×	112 0.5×	114 0.5×	69	1.8k

Countries citing papers authored by Qiubing Chen

Since Specialization

Citations

This map shows the geographic impact of Qiubing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiubing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiubing Chen more than expected).

Fields of papers citing papers by Qiubing Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiubing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiubing Chen. The network helps show where Qiubing Chen may publish in the future.

Co-authorship network of co-authors of Qiubing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qiubing Chen. A scholar is included among the top collaborators of Qiubing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiubing Chen. Qiubing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xianying, Qiubing Chen, Peixuan Chen, et al.. (2025). A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression. Virologica Sinica. 40(5). 793–803.

Lei, Xinlin, Didi Chen, Jinlin Wang, et al.. (2024). Rapid generation of long, chemically modified pegRNAs for prime editing. Nature Biotechnology. 43(7). 1156–1167. 12 indexed citations

Ding, Yi, Qiubing Chen, Dilare Adi, et al.. (2024). siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice. Journal of Lipid Research. 65(9). 100626–100626. 7 indexed citations

Chen, Qiubing, et al.. (2024). Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing. National Science Review. 11(6). nwae135–nwae135. 17 indexed citations

Lei, Xinlin, Qiubing Chen, Xueyong Chen, et al.. (2023). Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models. Antiviral Research. 215. 105618–105618. 24 indexed citations

An, Jing, Zhang Chuan-ping, Hou-Yuan Qiu, et al.. (2023). Enhancement of the viability of T cells electroporated with DNA via osmotic dampening of the DNA-sensing cGAS–STING pathway. Nature Biomedical Engineering. 8(2). 149–164. 36 indexed citations

Wang, Yalan, Qiubing Chen, Shuang Wu, et al.. (2023). Amelioration of ethanol-induced oxidative stress and alcoholic liver disease by in vivo RNAi targeting Cyp2e1. Acta Pharmaceutica Sinica B. 13(9). 3906–3918. 29 indexed citations

Wu, Shuang, Qiubing Chen, Yalan Wang, Hao Yin, & Yuan Wei. (2023). Lipid nanoparticle delivery of siRNA targeting Cyp2e1 gene attenuates subacute alcoholic liver injury in mice. Journal of Zhejiang University (Medical Sciences). 52(3). 306–317. 3 indexed citations

Chen, Qiubing, Menghang Zu, Hanlin Gong, et al.. (2023). Tea leaf-derived exosome-like nanotherapeutics retard breast tumor growth by pro-apoptosis and microbiota modulation. Journal of Nanobiotechnology. 21(1). 6–6. 124 indexed citations breakdown →

10.

Lu, Shuhan, Kun Zhang, Yizhou Zhang, et al.. (2022). Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a. Nature Biomedical Engineering. 6(3). 286–297. 272 indexed citations breakdown →

11.

Li, Qian, et al.. (2022). Cocktail strategy based on a dual function nanoparticle and immune activator for effective tumor suppressive. Journal of Nanobiotechnology. 20(1). 84–84. 17 indexed citations

12.

Wang, Guoquan, Rui Cheng, Qiubing Chen, et al.. (2022). mRNA produced by VSW-3 RNAP has high-level translation efficiency with low inflammatory stimulation. SHILAP Revista de lepidopterología. 1(5). 100056–100056. 14 indexed citations

13.

Chen, Qiubing, Qian Li, Yuqi Liang, et al.. (2021). Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharmaceutica Sinica B. 12(2). 907–923. 233 indexed citations breakdown →

14.

Wang, Lijie, Wei Xue, Hongxia Zhang, et al.. (2021). Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nature Cell Biology. 23(5). 552–563. 71 indexed citations

15.

Rao, Xi, Zilin Chen, Qiubing Chen, et al.. (2020). Tuning C–C sp2/sp3 ratio of DLC films in FCVA system for biomedical application. Bioactive Materials. 5(2). 192–200. 70 indexed citations

16.

Chen, Qiubing, Ying Zhang, & Hao Yin. (2020). Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing. Advanced Drug Delivery Reviews. 168. 246–258. 65 indexed citations

17.

Ma, Panpan, Shuangquan Gou, Ya Ma, et al.. (2019). Modulation of drug release by decoration with Pluronic F127 to improve anti-colon cancer activity of electrospun fibrous meshes. Materials Science and Engineering C. 99. 591–598. 10 indexed citations

18.

Zhou, Xin, Qiubing Chen, Ya Ma, et al.. (2019). Porous Polymeric Microparticles as an Oral Drug Platform for Effective Ulcerative Colitis Treatment. Journal of Pharmaceutical Sciences. 108(7). 2238–2242. 11 indexed citations

19.

Chen, Qiubing, Shuangquan Gou, Panpan Ma, et al.. (2018). Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy. International Journal of Pharmaceutics. 557. 135–144. 47 indexed citations

20.

Xiao, Bo, et al.. (2016). Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages. Journal of Colloid and Interface Science. 490. 520–528. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact